Funding Received
$41.7 Million in 1 Round from 4 Investors
Most Recent Funding
$41.7 Million Series A on April 8, 2013
Headquarters:
Paris
Description:
GenSight Biologics develops gene therapy-based treatments for retinal degenerative diseases.
Categories:
Biotechnology
Website:
http://www.gensight-biologics.com

Company Details

Update
Founded:
2011
Employees:
None found in CrunchBase

Paris-based GenSight Biologics is a privately owned biopharmaceutical company, dedicated to the development and commercialization of gene therapy based treatments of retinal degenerative diseases.

Based on recent results obtained by the teams of its scientific founders, the company develops innovative approaches to (i) prevent retinal degeneration in selected pathological conditions and (ii) to restore vision in patients suffering from very low vision or blindness.

Funding Rounds (1) - $41.7M

Update

Board Members and Advisors (2)

Update

Investors (4)

Update

Offices/Locations (1)

Update
  • Office

    Paris,

    FRA

Images (1)

Update
  • 709b41b936df8f56cb3e44b0987ff4dd